Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine

University of South Alabama

Overview

The purpose of this study is to determine if there are significant differences in the side effects related to memory, repetition and recall among these three drugs when used in a pediatric population.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Conditions

Migraine

Interventions

propranololDRUG

standard pediatric doses, based on body weight

zonisamideDRUG

standard pediatric dosages, based on body weight

topiramateDRUG

standard pediatric dosages, based on body weight

Eligibility

Sex: ALLMin age: 8 YearsMax age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosis of migraine with and without aura or chronic daily headache as defined by IHS * subjects must between the age of 8-17 (inclusive) Exclusion Criteria: * diagnosis of tension-type headache or cluster headache

Locations (1)

University of South Alabama Department of Neurology

Mobile, Alabama, United States

Outcomes

Primary Outcomes

Record if memory, repetition or recall was impaired by subject during specific time frame on medication.

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.